1. Home
  2. SMID vs MCRB Comparison

SMID vs MCRB Comparison

Compare SMID & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • MCRB
  • Stock Information
  • Founded
  • SMID 1960
  • MCRB 2010
  • Country
  • SMID United States
  • MCRB United States
  • Employees
  • SMID N/A
  • MCRB N/A
  • Industry
  • SMID Building Materials
  • MCRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMID Industrials
  • MCRB Health Care
  • Exchange
  • SMID Nasdaq
  • MCRB Nasdaq
  • Market Cap
  • SMID 229.0M
  • MCRB 165.3M
  • IPO Year
  • SMID 1995
  • MCRB 2015
  • Fundamental
  • Price
  • SMID $41.06
  • MCRB $19.52
  • Analyst Decision
  • SMID
  • MCRB Hold
  • Analyst Count
  • SMID 0
  • MCRB 4
  • Target Price
  • SMID N/A
  • MCRB $73.67
  • AVG Volume (30 Days)
  • SMID 12.1K
  • MCRB 121.3K
  • Earning Date
  • SMID 08-14-2025
  • MCRB 08-06-2025
  • Dividend Yield
  • SMID N/A
  • MCRB N/A
  • EPS Growth
  • SMID 162.25
  • MCRB N/A
  • EPS
  • SMID 2.27
  • MCRB 10.22
  • Revenue
  • SMID $90,998,000.00
  • MCRB N/A
  • Revenue This Year
  • SMID N/A
  • MCRB N/A
  • Revenue Next Year
  • SMID N/A
  • MCRB N/A
  • P/E Ratio
  • SMID $18.99
  • MCRB $1.91
  • Revenue Growth
  • SMID 32.97
  • MCRB N/A
  • 52 Week Low
  • SMID $25.13
  • MCRB $6.53
  • 52 Week High
  • SMID $51.96
  • MCRB $26.40
  • Technical
  • Relative Strength Index (RSI)
  • SMID 55.38
  • MCRB 67.61
  • Support Level
  • SMID $39.36
  • MCRB $18.43
  • Resistance Level
  • SMID $43.52
  • MCRB $20.59
  • Average True Range (ATR)
  • SMID 2.03
  • MCRB 1.30
  • MACD
  • SMID -0.09
  • MCRB 0.06
  • Stochastic Oscillator
  • SMID 54.39
  • MCRB 80.37

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: